Mel Sorensen - Net Worth and Insider Trading
Mel Sorensen Net Worth
The estimated net worth of Mel Sorensen is at least $60,631 dollars as of 2024-04-30. Mel Sorensen is the President and CEO of Galera Therapeutics Inc and owns about 332,044 shares of Galera Therapeutics Inc (GRTX) stock worth over $60,631. Details can be seen in Mel Sorensen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mel Sorensen has not made any transactions after 2023-03-10 and currently still holds the listed stock(s).
Transaction Summary of Mel Sorensen
Mel Sorensen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mel Sorensen owns 2 companies in total, including Galera Therapeutics Inc (GRTX) , and Lixte Biotechnology Holdings Inc (LIXT) .
Click here to see the complete history of Mel Sorensen’s form 4 insider trades.
Insider Ownership Summary of Mel Sorensen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2023-03-10 | director & President and CEO |
| LIXT | Lixte Biotechnology Holdings Inc | 2008-10-07 | director |
Mel Sorensen Latest Holdings Summary
Mel Sorensen currently owns a total of 1 stock. Mel Sorensen owns 332,044 shares of Galera Therapeutics Inc (GRTX) as of March 10, 2023, with a value of $60,631.
Latest Holdings of Mel Sorensen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2023-03-10 | 332,044 | 0.18 | 60,631 |
Holding Weightings of Mel Sorensen
Mel Sorensen Form 4 Trading Tracker
According to the SEC Form 4 filings, Mel Sorensen has made a total of 1 transactions in Galera Therapeutics Inc (GRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galera Therapeutics Inc is the acquisition of 100,000 shares on March 10, 2023, which cost Mel Sorensen around $168,000.
Insider Trading History of Mel Sorensen
- 1
Mel Sorensen Trading Performance
GuruFocus tracks the stock performance after each of Mel Sorensen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mel Sorensen is 89.44%. GuruFocus also compares Mel Sorensen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mel Sorensen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mel Sorensen's insider trading performs compared to the benchmark.
Performance of Mel Sorensen
Average Return
-86%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 55.43 | 89.44 | -88.39 | -86 | ||
| Relative Return to S&P 500(%) | 49.02 | 78.12 | -103.82 | -118.68 |
Mel Sorensen Ownership Network
Ownership Network List of Mel Sorensen
Ownership Network Relation of Mel Sorensen
Mel Sorensen Owned Company Details
What does Galera Therapeutics Inc do?
Who are the key executives at Galera Therapeutics Inc?
Mel Sorensen is the director & President and CEO of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include Chief Commercial Officer Mark Bachleda , Chief Financial Officer Chris Degnan , and Chief Medical Officer Eugene P. Kennedy .
Galera Therapeutics Inc (GRTX) Insider Trades Summary
Over the past 18 months, Mel Sorensen made 1 insider transaction in Galera Therapeutics Inc (GRTX) with a net purchase of 100,000. Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 932,402 shares made by , a net purchase of 11,000 shares made by Mark Bachleda , and a net purchase of 10,000 shares made by Chris Degnan .
In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc (GRTX) in total and bought 932,402 shares, with a net purchase of 932,402 shares. During the past 18 months, 0 shares of Galera Therapeutics Inc (GRTX) were sold and 1,053,402 shares were bought by its insiders, resulting in a net purchase of 1,053,402 shares.
Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galera Therapeutics Inc Insider Transactions
Mel Sorensen Mailing Address
Above is the net worth, insider trading, and ownership report for Mel Sorensen. You might contact Mel Sorensen via mailing address: 7 Rapps Run Drive, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
